Erik S. Musiek

Erik S. Musiek

Auto-generated profile, based on publicly available information

Erik S. Musiek

Department of Neurology, Washington University School of Medicine, St. Louis, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2016 in Science
Verified
Journal Article
Closed access
PDF file
EMErik S. Musiek
Erik S. Musiek
DHDavid M. Holtzman
David M. Holtzman
Disruptions of normal circadian rhythms and sleep cycles are consequences of aging and can profoundly affect health. Accumulating evidence indicates that circadian and sleep disturbances, which have long been considered symptoms of many neurodegenerative conditions, may actually drive pathogenesis early in the course of these diseases. In this Review, we explore potential cellular and molecular mechanisms linking circadian dysfunction and sleep loss to neurodegenerative diseases, with a focus on Alzheimer’s disease. We examine the interplay between central and peripheral circadian rhythms, circadian clock gene function, and sleep in maintaining brain homeostasis, and discuss therapeutic implications. The circadian clock and sleep can influence a number of key processes involved in neurodegeneration, suggesting that these systems might be manipulated to promote healthy brain aging.

26 May 2015 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
EMErik S Musiek
Erik S Musiek
DHDavid Holtzman
David Holtzman

13 March 2015 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
EMErik S Musiek
Erik S Musiek
DXDavid D Xiong
David D Xiong
DHDavid Holtzman
David Holtzman
Disturbances in the sleep–wake cycle and circadian rhythms are common symptoms of Alzheimer Disease (AD), and they have generally been considered as late consequences of the neurodegenerative processes. Recent evidence demonstrates that sleep–wake and circadian disruption often occur early in the course of the disease and may even precede the development of cognitive symptoms. Furthermore, the sleep–wake cycle appears to regulate levels of the pathogenic amyloid-beta peptide in the brain, and manipulating sleep can influence AD-related pathology in mouse models via multiple mechanisms. Finally, the circadian clock system, which controls the sleep–wake cycle and other diurnal oscillations in mice and humans, may also have a role in the neurodegenerative process. In this review, we examine the current literature related to the mechanisms by which sleep and circadian rhythms might impact AD pathogenesis, and we discuss potential therapeutic strategies targeting these systems for the prevention of AD.

25 November 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
EMErik S. Musiek
Erik S. Musiek
MLMiranda M. Lim
Miranda M. Lim
GYGuangrui Yang
Guangrui Yang
ABAdam Q. Bauer
Adam Q. Bauer
LQLaura Qi
Laura Qi
GFGarret A. FitzGerald
Garret A. FitzGerald
Brain aging is associated with diminished circadian clock output and decreased expression of the core clock proteins, which regulate many aspects of cellular biochemistry and metabolism. The genes encoding clock proteins are expressed throughout the brain, though it is unknown whether these proteins modulate brain homeostasis. We observed that deletion of circadian clock transcriptional activators aryl hydrocarbon receptor nuclear translocator–like (Bmal1) alone, or circadian locomotor output cycles kaput (Clock) in combination with neuronal PAS domain protein 2 (Npas2), induced severe age-dependent astrogliosis in the cortex and hippocampus. Mice lacking the clock gene repressors period circadian clock 1 (Per1) and period circadian clock 2 (Per2) had no observed astrogliosis. Bmal1 deletion caused the degeneration of synaptic terminals and impaired cortical functional connectivity, as well as neuronal oxidative damage and impaired expression of several redox defense genes. Targeted deletion of Bmal1 in neurons and glia caused similar neuropathology, despite the retention of intact circadian behavioral and sleep-wake rhythms. Reduction of Bmal1 expression promoted neuronal death in primary cultures and in mice treated with a chemical inducer of oxidative injury and striatal neurodegeneration. Our findings indicate that BMAL1 in a complex with CLOCK or NPAS2 regulates cerebral redox homeostasis and connects impaired clock gene function to neurodegeneration.

3 February 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
GYGuangrui Yang
Guangrui Yang
LCLihong Chen
Lihong Chen
GGGregory R. Grant
Gregory R. Grant
GPGeorgios Paschos
Georgios Paschos
WSWenliang Song
Wenliang Song
GFGarret A. FitzGerald
Garret A. FitzGerald
The absence of Bmal1, a core clock gene, results in a loss of circadian rhythms, an acceleration of aging, and a shortened life span in mice. To address the importance of circadian rhythms in the aging process, we generated conditional Bmal1 knockout mice that lacked the BMAL1 protein during adult life and found that wild-type circadian variations in wheel-running activity, heart rate, and blood pressure were abolished. Ocular abnormalities and brain astrogliosis were conserved irrespective of the timing of Bmal1 deletion. However, life span, fertility, body weight, blood glucose levels, and age-dependent arthropathy, which are altered in standard Bmal1 knockout mice, remained unaltered, whereas atherosclerosis and hair growth improved, in the conditional adult-life Bmal1 knockout mice, despite abolition of clock function. Hepatic RNA-Seq revealed that expression of oscillatory genes was dampened in the adult-life Bmal1 knockout mice, whereas overall gene expression was largely unchanged. Thus, many phenotypes in conventional Bmal1 knockout mice, hitherto attributed to disruption of circadian rhythms, reflect the loss of properties of BMAL1 that are independent of its role in the clock. These findings prompt reevaluation of the systemic consequences of disruption of the molecular clock.

1 January 2007 in Nature Protocols
Verified
Journal Article
Closed access
GMGinger L Milne
Ginger L Milne
SSStephanie C Sanchez
Stephanie C Sanchez
EMErik S Musiek
Erik S Musiek
JMJason D Morrow
Jason D Morrow